BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8674299)

  • 1. Tc-99m sestamibi uptake and retention in a large hepatoma.
    Sutter CW; Shelton DK
    Clin Nucl Med; 1995 Dec; 20(12):1091. PubMed ID: 8674299
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of technetium-99m methoxyisobutylisonitrile liver single photon emission computed tomography to detect hepatocellular carcinoma.
    Ho YJ; Jen LB; Yang MD; Kao CH; Lin CC; Lee CC
    Neoplasma; 2003; 50(2):117-9. PubMed ID: 12740645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m methoxyisobutylisonitrile single-photon emission tomography in hepatocellular carcinoma.
    Fukushima K; Kono M; Ishii K; Sakai E; Hirota S; Yuri H
    Eur J Nucl Med; 1997 Nov; 24(11):1426-8. PubMed ID: 9371878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma.
    Kim YS; Cho SW; Lee KJ; Hahm KB; Wang HJ; Yim H; Jin YM; Park CH
    Clin Nucl Med; 1999 Nov; 24(11):874-9. PubMed ID: 10551471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m sestamibi uptake in hepatocellular carcinoma.
    Derebek E
    Eur J Nucl Med; 1998 Nov; 25(11):1587-8. PubMed ID: 9882185
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidental detection of hepatocellular carcinoma by SPECT myocardial perfusion imaging.
    Bhambhvani P; Dubovsky E; Heo J; Iskandrian A
    J Nucl Cardiol; 2010 Dec; 17(6):1116-7. PubMed ID: 20602264
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential uptake patterns of technetium-99m pyrophosphate in hepatoma.
    Yeh SH; Liu RS; Chuang CH; Tsai YT
    Clin Nucl Med; 1985 Dec; 10(12):844-7. PubMed ID: 3000681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT.
    Haste P; Tann M; Persohn S; LaRoche T; Aaron V; Mauxion T; Chauhan N; Dreher MR; Johnson MS
    J Vasc Interv Radiol; 2017 May; 28(5):722-730.e1. PubMed ID: 28238581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression.
    Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH
    Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelioid-type hepatocellular carcinoma masquerading as a hepatic hemangioma on technetium-99m red blood cell scintigraphy.
    Ji EK; Ryu JS; Kang GH; Moon DH; Auh YH; Lee HK
    Clin Nucl Med; 2001 Jan; 26(1):33-5. PubMed ID: 11139050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of hepatocellular carcinoma mimicking cavernous hemangioma on Tc-99m RBC liver SPECT.
    Lim ST; Sohn MH
    Clin Nucl Med; 2001 Mar; 26(3):253-4. PubMed ID: 11245128
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
    Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
    Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tc-99m red blood cell scintigraphy in acute intrahepatic hematoma.
    Growcock GW; Murray RR; Guzley GJ
    Clin Nucl Med; 1994 Aug; 19(8):752-3. PubMed ID: 7955767
    [No Abstract]   [Full Text] [Related]  

  • 14. A trial of single photon emission computed tomography of the liver with technetium-99m tetrofosmin to detect hepatocellular carcinoma.
    Ho YJ; Jeng LB; Yang MD; Kao CH; Lin CC; Lee CC
    Anticancer Res; 2003; 23(2C):1743-6. PubMed ID: 12820451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects.
    Sawada SG; Allman KC; Muzik O; Beanlands RS; Wolfe ER; Gross M; Fig L; Schwaiger M
    J Am Coll Cardiol; 1994 Jan; 23(1):92-8. PubMed ID: 8277101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration and clearance of Tc-99m-pyridoxylidene isoleucine by a hepatoma.
    Ueno K; Haseda Y
    Clin Nucl Med; 1980 May; 5(5):196-9. PubMed ID: 6245828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual presentation of hepatocellular carcinoma and assisted diagnosis by liver scan.
    Huang WS; Liu YC; Yu CY; Chou JM; Jen TK
    Clin Nucl Med; 2000 Jul; 25(7):563-4. PubMed ID: 10885709
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
    Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.
    Wang SJ; Lin WY; Wey SP; Shen LH; Ting G
    Neoplasma; 1999; 46(4):246-8. PubMed ID: 10613606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of embolization effect of hepatocellular carcinoma by hepatic arterial flow study with Tc-99m MAA SPECT.
    Lee BH; Yoo HS; Lee JD; Chung JI; Park CY; Lee JT
    Clin Nucl Med; 1995 Jul; 20(7):605-9. PubMed ID: 7554662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.